Hydrocodone/guaifenesin

Hydrocodone/guaifenesin, sold under the brand name Obredon among others, is a fixed-dose combination medication used for the treatment of cough.^[2] It contains hydrocodone, as the bitartrate, an opioid agonist; and guaifenesin, an expectorant.^[2] It is taken by mouth.^[2]

Hydrocodone/guaifenesin

Combination of
Hydrocodone	Opioid agonist
Guaifenesin	Expectorant
Clinical data
Trade names	Obredon, Flowtuss, others
AHFS/Drugs.com	Consumer Drug Information Consumer Drug Information
License data	US DailyMed: Hydrocodone and guaifenesin
Routes of administration	By mouth
ATC code	R05FA02 (WHO)
Legal status
Legal status	US: Schedule II[1][2]
Identifiers
CAS Number	941568-01-0
KEGG	D11087

Hydrocodone/guaifenesin was approved for medical use in the United States in 2014.^[3][4]

Adverse effects

In the US, the label for hydrocodone/guaifenesin contains a black box warning about addiction, abuse, and misuse.^[2]